We are live on
!
Find out more
Rocket Pharmaceuticals
RCKT
RCKT
67 hedge funds and large institutions have $20.7M invested in Rocket Pharmaceuticals in 2017 Q1 according to their latest regulatory filings, with 12 funds opening new positions, 21 increasing their positions, 18 reducing their positions, and 21 closing their positions.
New
Increased
Maintained
Reduced
Closed
861% more call options, than puts
Call options by funds: $1.02M | Put options by funds: $106K
17% more repeat investments, than reductions
Existing positions increased: 21 | Existing positions reduced: 18
0% more funds holding in top 10
Funds holding in top 10: 1 → 1 (0)
6.94% less ownership
Funds ownership: 16.53% → 9.59% (-6.9%)
18% less funds holding
Funds holding: 82 → 67 (-15)
43% less first-time investments, than exits
New positions opened: 12 | Existing positions closed: 21
81% less capital invested
Capital invested by funds: $109M → $20.7M (-$87.9M)
Holders
67
Holders Change
-15
Holders Change %
-18.29%
% of All Funds
1.67%
Holding in Top 10
1
Holding in Top 10 Change
–
Holding in Top 10 Change %
–
% of All Funds
0.02%
New
12
Increased
21
Reduced
18
Closed
21
Calls
$1.02M
Puts
$106K
Net Calls
+$913K
Net Calls Change
-$775K
Top Buyers
| 1 |
BlackRock
New York
|
+$1.66M |
| 2 |
SCM
Sio Capital Management
New York
|
+$1.22M |
| 3 |
SAM
Senzar Asset Management
New York
|
+$739K |
| 4 |
FO
FT Options
Chicago,
Illinois
|
+$499K |
| 5 |
Vanguard Group
Malvern,
Pennsylvania
|
+$488K |
Top Sellers
| 1 |
Jennison Associates
New York
|
-$12.1M |
| 2 |
O
OrbiMed
New York
|
-$11.3M |
| 3 |
GPP
Great Point Partners
Greenwich,
Connecticut
|
-$9.15M |
| 4 |
Franklin Resources
San Mateo,
California
|
-$8.05M |
| 5 |
T. Rowe Price Associates
Baltimore,
Maryland
|
-$5.77M |
